Valuation : PHARMING GROUP

Market Cap 70Cr 81Cr 66Cr 60Cr 113.28Cr 7.77TCr 113.77Cr 781.9Cr 305.26Cr 3.93TCr 305.88Cr 299.23Cr 13TCr P/E 2026 *
26.8x
P/E 2027 * 34.4x
Enterprise Value 65Cr 75Cr 61Cr 56Cr 104.77Cr 7.19TCr 105.22Cr 723.17Cr 282.33Cr 3.64TCr 282.9Cr 276.76Cr 12TCr EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.45x
Free-Float
98.05%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 04/03/2025
Director of Finance/CFO 58 01/10/2025
Chief Tech/Sci/R&D Officer 54 01/06/2021
Director TitleAgeSince
Director/Board Member 71 11/12/2020
Director/Board Member 62 11/12/2020
Director/Board Member 60 19/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-6.44%+60.47%+112.05% 1,04700Cr
+0.85%-0.81%+52.77%+63.15% 65TCr
-1.03%-3.58%+22.87%+73.29% 45TCr
-1.46%-4.50%+37.43%+38.41% 35TCr
-0.72%-2.89%+21.86%+36.79% 29TCr
-1.19%-2.21%+1.35%+12.29% 25TCr
-1.05%-1.57%+51.40%+68.55% 23TCr
+0.08%-1.78%-17.64%-54.29% 20TCr
-2.14%-0.30%+29.42%+89.10% 18TCr
Average -0.75%-2.68%+28.88%+48.82% 40.66TCr
Weighted average by Cap. -0.46%-3.46%+38.66%+65.51%

Financials

2026 *2027 *
Net sales 38Cr 44Cr 36Cr 33Cr 62Cr 4.23TCr 62Cr 425.44Cr 166.09Cr 2.14TCr 166.43Cr 162.82Cr 7.09TCr 42Cr 49Cr 40Cr 36Cr 68Cr 4.69TCr 69Cr 472.18Cr 184.34Cr 2.37TCr 184.72Cr 180.71Cr 7.87TCr
Net income 2.1Cr 2.44Cr 1.97Cr 1.8Cr 3.39Cr 232.41Cr 3.4Cr 23Cr 9.13Cr 117.53Cr 9.15Cr 8.95Cr 389.69Cr 2.96Cr 3.43Cr 2.78Cr 2.53Cr 4.77Cr 327.2Cr 4.79Cr 33Cr 13Cr 165.46Cr 13Cr 13Cr 548.62Cr
Net Debt -5.28Cr -6.12Cr -4.95Cr -4.52Cr -8.51Cr -583.78Cr -8.54Cr -59Cr -23Cr -295.22Cr -23Cr -22Cr -978.85Cr -8.64Cr -10Cr -8.1Cr -7.39Cr -14Cr -954.36Cr -14Cr -96Cr -37Cr -482.62Cr -38Cr -37Cr -1.6TCr
Logo PHARMING GROUP
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The group is developing and commercializing a portfolio of innovative medicines, including small molecules and biologics.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-